Story

The article discusses the emergence of nitazenes, a new class of synthetic opioids, which pose significant health risks and have been fueled by the ongoing failure of drug prohibition policies. It highlights the need for a new approach to drug policy that prioritizes harm reduction and public health over criminalization.